Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis
PHASE3CompletedINTERVENTIONAL
Enrollment
90
Participants
Timeline
Start Date
November 30, 2006
Primary Completion Date
August 31, 2007
Study Completion Date
August 31, 2007
Conditions
Allergic Conjunctivitis
Interventions
DRUG
Bromfenac
DRUG
Placebo
Trial Locations (1)
92618
ISTA Pharmaceuticals, Inc., Irvine
All Listed Sponsors
lead
Bausch & Lomb Incorporated
INDUSTRY
NCT00423007 - Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis | Biotech Hunter | Biotech Hunter